Literature DB >> 15973171

Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.

Basma F Benabdallah1, Manaf Bouchentouf, Jacques P Tremblay.   

Abstract

BACKGROUND: : Duchenne muscular dystrophy (DMD) is caused by a dystrophin gene mutation. Transplantation of normal myoblasts results in long-term restoration of dystrophin. However, the success of this approach is compromised by the limited time of regeneration following muscle damage. Myostatin is known to be responsible for limiting skeletal muscle regeneration. Our purpose is to verify whether blocking the myostatin signal in mdx host mice or in normal myoblasts transplanted in mdx host mice would increase the extent of muscle repair and thus allow the formation of more dystrophin-positive fibers.
METHODS: : Transgenic mdx mice carrying a dominant negative form of myostatin receptor (dnActRIIB) were used to test the fiber resistance to damage and to act as a host for normal myoblast transplantation. Myoblasts obtained from nondystrophic transgenic mice carrying the dominant negative myostatin receptor were also transplanted in nontransgenic mdx mice.
RESULTS: : Transgenic mdx mice carrying the dnActRIIB gene have bigger muscles than mdx mice with the normal gene of ActRIIB. Their fiber resistance to exercise-induced damage was also greatly improved. Moreover, the success of normal myoblast transplantation was significantly enhanced in mdx/dnActRIIB mice. Finally, nondystrophic dnActRIIB myoblasts formed more abundant and bigger dystrophin positive fibers when transplanted in mdx mice.
CONCLUSIONS: : Blocking the myostatin signal in mdx mice allowed the size of muscle fibers to increase, the fiber resistance to damage induced by exercise to increase, and the success of normal myoblast transplantation to improve. The transplantation in mdx mice of dnActRIIB myoblasts formed more abundant and larger dystrophin positive fibers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973171     DOI: 10.1097/01.tp.0000167379.27872.2b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Kevin J Morine; Lawrence T Bish; Joshua T Selsby; Jeffery A Gazzara; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; Se-Jin Lee; H Lee Sweeney
Journal:  Muscle Nerve       Date:  2010-11       Impact factor: 3.217

2.  Not an inside job: how can transplantation of relatively few exogenous satellite cells do what thousands of endogenous cells cannot?

Authors:  Jacques P Tremblay; Daniel Skuk; Robert Frederickson
Journal:  Mol Ther       Date:  2011-01       Impact factor: 11.454

3.  Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.

Authors:  Raouia Fakhfakh; Se-Jin Lee; Jacques P Tremblay
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

4.  Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.

Authors:  Raouia Fakhfakh; Annick Michaud; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

5.  A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration.

Authors:  Michael V Khanjyan; Jonathan Yang; Refik Kayali; Thomas Caldwell; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2013-04-23       Impact factor: 6.150

Review 6.  Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

Authors:  Buel D Rodgers; Dilip K Garikipati
Journal:  Endocr Rev       Date:  2008-06-30       Impact factor: 19.871

Review 7.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

8.  Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle.

Authors:  Pierre-François Lesault; Marine Theret; Mélanie Magnan; Sylvain Cuvellier; Yiming Niu; Romain K Gherardi; Jacques P Tremblay; Luc Hittinger; Bénédicte Chazaud
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

9.  Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells.

Authors:  Elise Jean; Dalila Laoudj-Chenivesse; Cécile Notarnicola; Karl Rouger; Nicolas Serratrice; Anne Bonnieu; Stéphanie Gay; Francis Bacou; Cédric Duret; Gilles Carnac
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

Review 10.  Concise Review: Epigenetic Regulation of Myogenesis in Health and Disease.

Authors:  Marie-Claude Sincennes; Caroline E Brun; Michael A Rudnicki
Journal:  Stem Cells Transl Med       Date:  2016-01-21       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.